Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by P. A. Beavis
Anti-Pd-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors by Gene-Modified T Cells
Clinical Cancer Research
Cancer Research
Oncology
Related publications
771. Overcoming Resistance to Antibody Targeted Therapy in Cancer Using Gene-Modified T Cells
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Rationale of Combination of Anti-Pd-1/Pd-L1 Antibody Therapy and Radiotherapy for Cancer Treatment
International Journal of Clinical Oncology
Medicine
Surgery
Oncology
Hematology
Improved Survival of CAR‐T and Tumor‐specific T Cells Caused by Anti‐PD‐1 scFv‐producing CAR‐T Cells
Cancer Science
Cancer Research
Medicine
Oncology
Imaging of Activated T Cells as an Early Predictor of Immune Response to Anti-Pd-1 Therapy
Cancer Research
Cancer Research
Oncology
Phase I Study of Nivolumab, an Anti-Pd-1 Antibody, in Patients With Malignant Solid Tumors
Investigational New Drugs
Oncology
Pharmacology
Transduction of Human Dendritic Cells With Adenovirus Encoding Anti-Pd-1 Reduces PD-1 Expression on Co-Cultured T Cells
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
LPA4-mediated Vascular Network Formation Increases the Efficacy of Anti-Pd-1 Therapy Against Brain Tumors
Cancer Research
Cancer Research
Oncology
Modified T Cells Home to Brain Tumors
Cancer Discovery
Oncology
Reinvigorating Exhausted T Cells by Blockade of the PD-1 Pathway
Forum on Immunopathological Diseases and Therapeutics
Biochemistry
Biotechnology
Genetics
Molecular Medicine